510 related articles for article (PubMed ID: 25726713)
1. Hedgehog inhibitors: a patent review (2013 - present).
Xin M
Expert Opin Ther Pat; 2015 May; 25(5):549-65. PubMed ID: 25726713
[TBL] [Abstract][Full Text] [Related]
2. Discovery and preclinical development of vismodegib.
Gould SE; Low JA; Marsters JC; Robarge K; Rubin LL; de Sauvage FJ; Sutherlin DP; Wong H; Yauch RL
Expert Opin Drug Discov; 2014 Aug; 9(8):969-84. PubMed ID: 24857041
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in the design of Hedgehog pathway inhibitors for the treatment of malignancies.
Banerjee U; Hadden MK
Expert Opin Drug Discov; 2014 Jul; 9(7):751-71. PubMed ID: 24850423
[TBL] [Abstract][Full Text] [Related]
4. Targeting the hedgehog pathway to treat basal cell carcinoma.
Geeraert P; Williams JS; Brownell I
J Drugs Dermatol; 2013 May; 12(5):519-23. PubMed ID: 23652945
[TBL] [Abstract][Full Text] [Related]
5. Vismodegib: an inhibitor of the Hedgehog signaling pathway in the treatment of basal cell carcinoma.
Proctor AE; Thompson LA; O'Bryant CL
Ann Pharmacother; 2014 Jan; 48(1):99-106. PubMed ID: 24259609
[TBL] [Abstract][Full Text] [Related]
6. Vismodegib.
Meiss F; Andrlová H; Zeiser R
Recent Results Cancer Res; 2018; 211():125-139. PubMed ID: 30069764
[TBL] [Abstract][Full Text] [Related]
7. Vismodegib.
Meiss F; Zeiser R
Recent Results Cancer Res; 2014; 201():405-17. PubMed ID: 24756807
[TBL] [Abstract][Full Text] [Related]
8. Hedgehog pathway inhibitors: a patent review (2009--present).
Hadden MK
Expert Opin Ther Pat; 2013 Mar; 23(3):345-61. PubMed ID: 23294277
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of Hedgehog pathway activation in cancer and implications for therapy.
Scales SJ; de Sauvage FJ
Trends Pharmacol Sci; 2009 Jun; 30(6):303-12. PubMed ID: 19443052
[TBL] [Abstract][Full Text] [Related]
10. Hedgehog signaling pathway inhibitors: an updated patent review (2015-present).
Quaglio D; Infante P; Di Marcotullio L; Botta B; Mori M
Expert Opin Ther Pat; 2020 Apr; 30(4):235-250. PubMed ID: 32070165
[No Abstract] [Full Text] [Related]
11. Discovery of a potent hedgehog pathway inhibitor capable of activating caspase8-dependent apoptosis.
Chen Q; Zhang H; Wu M; Wang Q; Luo L; Ma H; Zhang X; He S
J Pharmacol Sci; 2018 Jul; 137(3):256-264. PubMed ID: 30064819
[TBL] [Abstract][Full Text] [Related]
12. Hedgehog signaling pathway and cancer therapeutics: progress to date.
Ruch JM; Kim EJ
Drugs; 2013 May; 73(7):613-23. PubMed ID: 23605693
[TBL] [Abstract][Full Text] [Related]
13. Recent patents for Hedgehog pathway inhibitors for the treatment of malignancy.
Tremblay MR; Nesler M; Weatherhead R; Castro AC
Expert Opin Ther Pat; 2009 Aug; 19(8):1039-56. PubMed ID: 19505195
[TBL] [Abstract][Full Text] [Related]
14. Clinical experience with Hedgehog pathway inhibitors.
Low JA; de Sauvage FJ
J Clin Oncol; 2010 Dec; 28(36):5321-6. PubMed ID: 21041712
[TBL] [Abstract][Full Text] [Related]
15. Targeting Hedgehog signaling and understanding refractory response to treatment with Hedgehog pathway inhibitors.
Queiroz KC; Spek CA; Peppelenbosch MP
Drug Resist Updat; 2012 Aug; 15(4):211-22. PubMed ID: 22910179
[TBL] [Abstract][Full Text] [Related]
16. Locally advanced and metastatic basal cell carcinoma: molecular pathways, treatment options and new targeted therapies.
Ruiz Salas V; Alegre M; Garcés JR; Puig L
Expert Rev Anticancer Ther; 2014 Jun; 14(6):741-9. PubMed ID: 24611655
[TBL] [Abstract][Full Text] [Related]
17. Crosstalk between hedgehog and other signaling pathways as a basis for combination therapies in cancer.
Brechbiel J; Miller-Moslin K; Adjei AA
Cancer Treat Rev; 2014 Jul; 40(6):750-9. PubMed ID: 24613036
[TBL] [Abstract][Full Text] [Related]
18. Strategies to target the Hedgehog signaling pathway for cancer therapy.
Xin M; Ji X; De La Cruz LK; Thareja S; Wang B
Med Res Rev; 2018 May; 38(3):870-913. PubMed ID: 29315702
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of vismodegib : a new therapeutic agent in the treatment of basal cell carcinoma.
Lyons TG; O'Kane GM; Kelly CM
Expert Opin Drug Saf; 2014 Aug; 13(8):1125-32. PubMed ID: 25033383
[TBL] [Abstract][Full Text] [Related]
20. Vismodegib and the hedgehog pathway: a new treatment for basal cell carcinoma.
Cirrone F; Harris CS
Clin Ther; 2012 Oct; 34(10):2039-50. PubMed ID: 23036338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]